Halozyme Therapeutics Inc
LSE:0J2O
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Halozyme Therapeutics Inc
LSE:0J2O
|
US |
|
Iberdrola SA
OTC:IBDSF
|
ES |
|
C
|
Central Plains Bancshares Inc
NASDAQ:CPBI
|
US |
|
K
|
Kingsmen CMTI PCL
SET:K
|
TH |
|
S
|
SBI Investment Korea Co Ltd
KOSDAQ:019550
|
KR |
|
Cellectar Biosciences Inc
NASDAQ:CLRB
|
US |
|
MI Technovation Bhd
OTC:MITNF
|
MY |
|
T
|
Thanachart Capital PCL
SET:TCAP
|
TH |
|
S
|
Sinaran Advance Group Bhd
KLSE:SINARAN
|
CN |
|
C
|
CalciMedica Inc
NASDAQ:CALC
|
US |
|
Swiss Properties Invest A/S
CSE:SWISS
|
DK |
|
R
|
Regina Miracle International (Holdings) Ltd
SWB:RMT
|
HK |
|
Natura City Developments Tbk PT
IDX:CITY
|
ID |
|
C
|
CPR Gomu Industrial PCL
SET:CPR
|
TH |
|
Pro Medicus Ltd
OTC:PMDIY
|
AU |
|
Lincoln Educational Services Corp
NASDAQ:LINC
|
US |
|
B
|
Brown & Brown Inc
DUS:BTW
|
US |
Shareholder Yield
Current shareholder yield for 
0J2O is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0J2O Price
Halozyme Therapeutics Inc
| Average Annual Return | 79.36% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -24% |
| Market Capitalization | 13.9B USD |
| Shares Outstanding | 117 600 000 |
| Percentage of Shares Shorted |
N/A
|
